Opus Point Partners Management’s Medicines Co MDCO Stock Holding History

Opus Point Partners Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,000	Closed	-$257K	–	52
2018 Q2	$257K	Hold	7,000	–	–	0.56%	42
2018 Q1	$231K	Sell	7,000 -7,000	-50%	-$219K	0.45%	46
2017 Q4	$383K	Hold	14,000	–	–	0.33%	43
2017 Q3	$519K	Hold	14,000	–	–	0.47%	48
2017 Q2	$532K	Sell	14,000 -14,000	-50%	-$624K	0.49%	44
2017 Q1	$1.37M	Hold	28,000	–	–	1.02%	32
2016 Q4	$950K	Hold	28,000	–	–	0.76%	34
2016 Q3	$1.06M	Buy	28,000 +14,115	+102%	+$532K	0.59%	30
2016 Q2	$467K	Sell	13,885 -26,615	-66%	-$938K	0.45%	34
2016 Q1	$1.29M	Buy	40,500 +15,500	+62%	+$506K	1%	30
2015 Q4	$934K	Buy	+25,000	New	+$945K	0.62%	43

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Opus Point Partners Management's MDCO Position: Q3 2018 in Review

Opus Point Partners Management sold out of Medicines Co (MDCO) in Q3 2018, closing a stake of 7,000 shares — an estimated $257K sold.

Opus Point Partners Management first reported a position in MDCO in Q4 2015 and held it in 11 quarters. The position peaked at $1.37M in Q1 2017. 184 funds tracked by Wall St. Rank hold MDCO as of Q3 2018.

Opus Point Partners Management reported no remaining Medicines Co position as of Q3 2018 after selling out during the quarter.
Opus Point Partners Management sold 7,000 Medicines Co shares in Q3 2018, an estimated $257K.
Opus Point Partners Management first reported a position in Medicines Co in Q4 2015 and held it in 11 quarters.
Opus Point Partners Management's Medicines Co position peaked at $1.37M in Q1 2017.
184 funds tracked by Wall St. Rank held Medicines Co as of Q3 2018.

Based on Opus Point Partners Management's 13F filing for Q3 2018, filed 14 Nov 2018.